The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Self-citationPembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Self-citationNivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Self-citationIpilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Self-citationTechnical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
Morton, D. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040034005 · Cited by 4,371
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Hauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
Self-citationDistinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., Lichinitser, M., Dummer, R., Grange, F., Mortier, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412690 · Cited by 2,701
Self-citationTalimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3377 · Cited by 2,634
Self-citationAndrews, D. W., Scott, C. B., Sperduto, P. W., Flanders, A. E., Gaspar, L. E., Schell, M. C., Werner-Wasik, M., Demas, W., Ryu, J., Bahary, J.-P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16250-8 · Cited by 2,417
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L. V., Hassel, J. C., Rutkowski, P., Mohr, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203421 · Cited by 2,160
Self-citationSurvival in BRAF V600-mutant advanced melanoma treated with vemurafenib
Sosman, J. A., Kim, K. B., Schuchter, L., Gonzalez, R., Pavlick, A. C., Weber, J. S., McArthur, G. A., Hutson, T. E., Moschos, S. J., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112302 · Cited by 2,156
The histogenesis and biologic behavior of primary human malignant melanomas of the skin.
Clark, W. H., From, L., Bernardino, E. A., & Mihm, M. C. (1969) · PubMed · Cited by 2,112
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,094
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Self-citationPostoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915
Sentinel-Node Biopsy or Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060992 · Cited by 1,824
Somatic Activation of KIT in Distinct Subtypes of Melanoma
Curtin, J. A., Busam, K., Pinkel, D., & Bastian, B. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2984 · Cited by 1,616
Diagnostic accuracy of dermoscopy
Kittler, H., Pehamberger, H., Wolff, K., & Binder, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00679-4 · Cited by 1,349
Self-citationImproved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M. M., Демидов, Л. В., Hassel, J. C., Rutkowski, P. L., Mohr, P., et al. (2012) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-63198 · Cited by 1,330
Self-citationMiddleton, M. R., Grob, J. J., Aaronson, N., Fierlbeck, G., Tilgen, W., Seiter, S., Gore, M., Aamdal, S., Cebon, J., Coates, A., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.158 · Cited by 1,272
Self-citationEggermont, A. M. M., Chiarion-Sileni, V., Grob, J.-J., Dummer, R., Wolchok, J. D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P. A., Richards, J. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70122-1 · Cited by 1,262
Self-citationDermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet
Argenziano, G., Soyer, H. P., Chimenti, S., Talamini, R., Corona, R., Sera, F., Binder, M., Cerroni, L., De Rosa, G., Ferrara, G., et al. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.281 · Cited by 1,208
Self-citationFalchook, G. S., Long, G. V., Kurzrock, R., Kim, K. B., Arkenau, T. H., Brown, M. P., Hamid, O., Infante, J. R., Millward, M., Pavlick, A. C., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60398-5 · Cited by 943
Long, G. V., Trefzer, U., Davies, M. A., Kefford, R. F., Ascierto, P. A., Chapman, P. B., Puzanov, I., Hauschild, A., Robert, C., Algazi, A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70431-x · Cited by 918
Self-citationGuidelines for Clinical Practice: From Development to Use
(1992) · National Academies Press eBooks · doi:10.17226/1863 · Cited by 915
Kirkwood, J. M., Ibrahim, J. G., Sondak, V. K., Richards, J., Flaherty, L. E., Ernstoff, M. S., Smith, T. J., Rao, U., Steele, M., & Blum, R. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2444 · Cited by 912
KIT as a Therapeutic Target in Metastatic Melanoma
Carvajal, R. D. (2011) · JAMA · doi:10.1001/jama.2011.746 · Cited by 888
Nachbar, F., Stolz, W., Merkle, T., Cognetta, A. B., Vogt, T., Landthaler, M., Bilek, P., Braun-Falco, O., & Plewig, G. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70061-3 · Cited by 882
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1509660 · Cited by 872
Management of Cutaneous Melanoma
Tsao, H., Atkins, M. B., & Sober, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041245 · Cited by 855
Chapman, P. B., Einhorn, L. H., Meyers, M. L., Saxman, S., Destro, A. N., Panageas, K. S., Begg, C. B., Agarwala, S. S., Schuchter, L. M., Ernstoff, M. S., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2745 · Cited by 764
Epidemiology of Melanoma and Nonmelanoma Skin Cancer—The Role of Sunlight
Leiter, U., & Garbe, C. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-77574-6_8 · Cited by 717
Self-citationMorton, D. L., Cochran, A. J., Thompson, J. F., Elashoff, R., Essner, R., Glass, E. C., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000181092.50141.fa · Cited by 715
Leiter, U., Stadler, R., Mauch, C., Hohenberger, W., Brockmeyer, N., Berking, C., Sunderkötter, C., Kaatz, M., Schulte, K.-W., Lehmann, P., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00141-8 · Cited by 707
Self-citationGuo, J., Si, L., Kong, Y., Flaherty, K. T., Xu, X., Zhu, Y., Corless, C. L., Li, L., Li, H., Sheng, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9275 · Cited by 688
Tumor Immunotherapy Directed at PD-1
Ribas, A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1205943 · Cited by 683
Determinants of BRAF Mutations in Primary Melanomas
Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg123 · Cited by 664 · cited 1×
“[28] Another group of roughly 10% of CMs seems to be characterised by mutations in the NF1 gene.”
BackgroundMelanoma epidemiology and trends
Garbe, C., & Leiter, U. (2009) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.001 · Cited by 657
Self-citationEggermont, A. M., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Salès, F., Gore, M., MacKie, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61033-8 · Cited by 640
Self-citationWhiteman, D. C., Green, A. C., & Olsen, C. M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.035 · Cited by 628
Bedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0483 · Cited by 600
Self-citationSystematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
Garbe, C., Eigentler, T. K., Keilholz, U., Hauschild, A., & Kirkwood, J. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0190 · Cited by 582
Self-citationEggermont, A. M., Spatz, A., & Robert, C. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60802-8 · Cited by 548
Self-citationMocellin, S., Pasquali, S., Rossi, C. R., & Nitti, D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq009 · Cited by 527
Number of melanocytic nevi as a major risk factor for malignant melanoma
Holly, E. A., Kelly, J. W., Shpall, S. N., & Chiu, S.-H. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70230-8 · Cited by 503
BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
Colombino, M., Capone, M., Lissia, A., Cossu, A., Rubino, C., De Giorgi, V., Massi, D., Fonsatti, E., Staibano, S., Nappi, O., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.2452 · Cited by 471
The classification of malignant melanoma and its histologic reporting
McGovern, V. J., Mihm, M. C., Bailly, C., Booth, J. C., Clark, W. H., Cochran, A. J., Hardy, E. G., Hicks, J. D., Levene, A., Lewis, M. G., et al. (1973) · Cancer · doi:10.1002/1097-0142(197312)32:6<1446::aid-cncr2820320623>3.0.co;2-8 · Cited by 443
Grob, J. J., Dreno, B., de la Salmoniere, P., Delaunay, M., Cupissol, D., Guillot, B., Souteyrand, P., Sassolas, B., Cesarini, J.-P., Lionnet, S., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12445-x · Cited by 433
Self-citationThe clinical development of MEK inhibitors
Zhao, Y., & Adjei, A. A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.83 · Cited by 400
Marsden, J. R., Newton-Bishop, J. A., Burrows, L., Cook, M., Corrie, P. G., Cox, N. H., Gore, M. E., Lorigan, P., MacKie, R., Nathan, P., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09883.x · Cited by 396
Self-citationImproving Melanoma Classification by Integrating Genetic and Morphologic Features
Viros, A., Fridlyand, J., Bauer, J., Lasithiotakis, K., Garbe, C., Pinkel, D., & Bastian, B. C. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050120 · Cited by 379
Self-citationThompson, J. F., Soong, S.-J., Balch, C. M., Gershenwald, J. E., Ding, S., Coit, D. G., Flaherty, K. T., Gimotty, P. A., Johnson, T., Johnson, M. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5812 · Cited by 363
Self-citationGreger, J. G., Eastman, S. D., Zhang, V., Bleam, M. R., Hughes, A. M., Smitheman, K. N., Dickerson, S. H., Laquerre, S. G., Liu, L., & Gilmer, T. M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0989 · Cited by 363
Grob, J. J., & Bonerandi, J. J. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.1.103-a · Cited by 331
Self-citationU.K. guidelines for the management of cutaneous melanoma
Roberts, D. L., Anstey, A. V., Barlow, R., Cox, N. H., Newton‐Bishop, J., Corrie, P. G., Evans, J., Gore, M. E., Hall, P. N., & Kirkham, N. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04614.x · Cited by 324
Self-citationEigentler, T. K., Caroli, U. M., Radny, P., & Garbe, C. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01280-4 · Cited by 324
Self-citationDiagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Spatz, A., Grob, J.-J., Malvehy, J., Newton-Bishop, J., Stratigos, A., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.032 · Cited by 317
Self-citationEggermont, A. M., Suciu, S., MacKie, R., Ruka, W., Testori, A., Kruit, W., Punt, C. J., Delauney, M., Sales, F., Groenewegen, G., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67482-x · Cited by 311
Self-citationDermoscopic Evaluation of Amelanotic and Hypomelanotic Melanoma
Menzies, S. W., Kreusch, J., Byth, K., Pizzichetta, M. A., Marghoob, A., Braun, R., Malvehy, J., Puig, S., Argenziano, G., Zalaudek, I., et al. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.9.1120 · Cited by 306
Self-citationBurmeister, B. H., Henderson, M. A., Ainslie, J., Fisher, R., Di Iulio, J., Smithers, B. M., Hong, A., Shannon, K., Scolyer, R. A., Carruthers, S., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70138-9 · Cited by 293
Eggermont, A. M. M., Suciu, S., Testori, A., Santinami, M., Kruit, W. H. J., Marsden, J., Punt, C. J. A., Salès, F., Dummer, R., Robert, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.3799 · Cited by 285
Self-citationImprovement of early recognition of lentigo maligna using dermatoscopy
Schiffner, R., Schiffner-Rohe, J., Vogt, T., Landthaler, M., Wlotzke, U., Cognetta, A. B., & Stolz, W. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90005-7 · Cited by 284
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
Bleehen, N. M., Newlands, E. S., Lee, S. M., Thatcher, N., Selby, P., Calvert, A. H., Rustin, G. J., Brampton, M., & Stevens, M. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.910 · Cited by 282
Whiteman, D. C., Pavan, W. J., & Bastian, B. C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00880.x · Cited by 273
A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma
Menzies, S. W., Ingvar, C., & McCarthy, W. H. (1996) · Melanoma Research · doi:10.1097/00008390-199602000-00008 · Cited by 267
Grob, J. J., Gouvernet, J., Aymar, D., Mostaque, A., Romano, M. H., Collet, A. M., Noe, M. C., Diconstanzo, M. P., & Bonerandi, J. J. (1990) · Cancer · doi:10.1002/1097-0142(19900715)66:2<387::aid-cncr2820660232>3.0.co;2-j · Cited by 259
Self-citationCascinelli, N., Belli, F., MacKie, R. M., Santinami, M., Bufalino, R., & Morabito, A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06068-8 · Cited by 250
Koops, H. S., Vaglini, M., Suciu, S., Kroon, B. B., Thompson, J. F., Göhl, J., Eggermont, A. M., Di Filippo, F., Krementz, E. T., Ruiter, D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2906 · Cited by 246
Self-citationMoschos, S. J., Edington, H. D., Land, S. R., Rao, U. N., Jukic, D., Shipe-Spotloe, J., & Kirkwood, J. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2498 · Cited by 242
Identification of Clinically Featureless Incipient Melanoma Using Sequential Dermoscopy Imaging
Kittler, H., Guitera, P., Riedl, E., Avramidis, M., Teban, L., Fiebiger, M., Weger, R. A., Dawid, M., & Menzies, S. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.9.1113 · Cited by 220
Patel, P. M., Suciu, S., Mortier, L., Kruit, W. H., Robert, C., Schadendorf, D., Trefzer, U., Punt, C. J. A., Dummer, R., Davidson, N., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.030 · Cited by 211
Self-citationBauer, J., & Garbe, C. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00047.x · Cited by 209
Self-citationGreen, A. C., Baade, P., Coory, M., Aitken, J. F., & Smithers, M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8561 · Cited by 206
KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites
Omholt, K., Grafström, E., Kanter-Lewensohn, L., Hansson, J., & Ragnarsson-Olding, B. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2917 · Cited by 194
Eggermont, A. M. M., Suciu, S., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Santinami, M., Salès, F., Schadendorf, D., Patel, P., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.028 · Cited by 192
Self-citationJoosse, A., Collette, S., Suciu, S., Nijsten, T., Lejeune, F., Kleeberg, U. R., Coebergh, J. W. W., Eggermont, A. M. M., & de Vries, E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0584 · Cited by 189
Self-citationFirst Prospective Study of the Recognition Process of Melanoma in Dermatological Practice
Gachon, J., Beaulieu, P., Sei, J. F., Gouvernet, J., Claudel, J. P., Lemaitre, M., Richard, M. A., & Grob, J. J. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.4.434 · Cited by 184
Self-citationGarbe, C., Krüger, S., Orfanos, C. E., Büttner, P., Weiß, J., Soyer, H. P., Stocker, U., Roser, M., Weckbecker, J., Panizzon, R., et al. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12374298 · Cited by 183
Self-citationMorton, D. L., Mozzillo, N., Thompson, J. F., Kelley, M. C., Faries, M., Wagner, J., Schneebaum, S., Schuchter, L., Gammon, G., & Elashoff, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8508 · Cited by 177
Alarcon, I., Carrera, C., Palou, J., Alos, L., Malvehy, J., & Puig, S. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12678 · Cited by 171
Self-citationDermoscopy of lentigo maligna melanoma: report of 125 cases
Pralong, P., Bathelier, E., Dalle, S., Poulalhon, N., Debarbieux, S., & Thomas, L. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10932.x · Cited by 165
Mihm, M. C., Clark, W. H., & From, L. (1971) · New England Journal of Medicine · doi:10.1056/nejm197105132841907 · Cited by 162
Hofmann, U., Szedlak, M., Rittgen, W., Jung, E. G., & Schadendorf, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600428 · Cited by 159
Hayes, A. J., Maynard, L., Coombes, G., Newton‐Bishop, J., Timmons, M. J., Cook, M. G., Theaker, J. M., Bliss, J. M., & Thomas, J. M. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00482-9 · Cited by 151
Self-citationWeide, B., Elsässer, M., Buttner, P. G., Pflugfelder, A., Leiter, U., Eigentler, T., Bauer, J. M., Witte, M. B., Meier, F. E., & Garbe, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.306 · Cited by 146
Self-citationDermoscopy for acral pigmented skin lesions
Saida, T., Oguchi, S., & Miyazaki, A. (2002) · Clinics in Dermatology · doi:10.1016/s0738-081x(02)00219-5 · Cited by 146
Haenssle, H. A., Krueger, U., Vente, C., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700119 · Cited by 142
Garbe, C., Radny, P., Linse, R., Dummer, R., Gutzmer, R., Ulrich, J., Stadler, R., Weichenthal, M., Eigentler, T., Ellwanger, U., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn001 · Cited by 138
Self-citationBlue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma
Argenziano, G., Longo, C., Cameron, A., Cavicchini, S., Gourhant, J.-Y., Lallas, A., McColl, I., Rosendahl, C. O., Thomas, L., Tiodorović-Živković, D., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10621.x · Cited by 131
Hauschild, A., Gogas, H. J., Tarhini, A. A., Middleton, M. R., Testori, A., Dréno, B., & Kirkwood, J. M. (2008) · Cancer · doi:10.1002/cncr.23251 · Cited by 130
Self-citationGarbe, C., Hauschild, A., Volkenandt, M., Schadendorf, D., Stolz, W., Reinhold, U., Kortmann, R., Kettelhack, C., Frerich, B., Keilholz, U., et al. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f05039 · Cited by 129
Self-citationCoit, D. G., Andtbacka, R. H. I., Bichakjian, C. K., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0020 · Cited by 126
Rao, R. D., Holtan, S. G., Ingle, J. N., Croghan, G. A., Kottschade, L. A., Creagan, E. T., Kaur, J. S., Pitot, H. C., & Markovic, S. N. (2005) · Cancer · doi:10.1002/cncr.21611 · Cited by 124
Handolias, D., Salemi, R., Murray, W. K., Tan, A., Liu, W. J., Virós, A., Dobrovic, A., Kelly, J. W., & McArthur, G. A. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00671.x · Cited by 122
A new era: melanoma genetics and therapeutics
Ko, J., & Fisher, D. E. (2010) · The Journal of Pathology · doi:10.1002/path.2804 · Cited by 117
Dermoscopic Patterns of Acral Melanocytic Nevi and Melanomas in a White Population in Central Italy
Altamura, D., Altobelli, E., Micantonio, T., Piccolo, D., Fargnoli, M. C., & Peris, K. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.9.1123 · Cited by 103
Self-citationSurveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy
Bauer, J. M., Blum, A., Strohhäcker, U., & Garbe, C. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06370.x · Cited by 103
Self-citationHansson, J., Aamdal, S., Bastholt, L., Brandberg, Y., Hernberg, M., Nilsson, B. R., Stierner, U. K., & von der Maase, H. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70288-6 · Cited by 103
Self-citationWasif, N., Bagaria, S. P., Ray, P. S., & Morton, D. L. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21903 · Cited by 101
Gaudy‐Marqueste, C., Régis, J.-M., Muracciole, X., Laurans, R., Richard, M. A., Bonerandi, J. J., & Grob, J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.024 · Cited by 97
Self-citationGarbe, C., Hauschild, A., Volkenandt, M., et al. (2008) · Melanoma Research · doi:10.1097/cmr.0b013e3282f0c893 · Cited by 91
Self-citationInterobserver reproducibility of ulceration assessment in primary cutaneous melanomas
Spatz, A., Cook, M. G., Elder, D. E., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00325-3 · Cited by 88
Eggermont, A. M. M., Suciu, S., Rutkowski, P. L., Kruit, W., Punt, C. J. A., Dummer, R., Salès, F., Keilholz, U., de Schaetzen, G., & Testori, A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.014 · Cited by 86
Self-citationWheatley, K., Wilson, J. S., Gaunt, P., & Marsden, J. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.10.013 · Cited by 82
Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma
Dummer, R., Guggenheim, M., Arnold, A., Braun, R. P., & von Moos, R. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13320 · Cited by 76
Deroose, J. P., Eggermont, A. M. M., van Geel, A. N., de Wilt, J. H. W., Burger, J. W. A., & Verhoef, C. K. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2030-7 · Cited by 75
Self-citationGarbe, C., Hauschild, A., Volkenandt, M., Schadendorf, D., Stolz, W., Reinhold, U., Kortmann, R., Kettelhack, C., Frerich, B., Keilholz, U., et al. (2008) · Melanoma Research · doi:10.1097/cmr.0b013e3282f702bf · Cited by 71
Self-citationManagement of familial melanoma
Newton‐Bishop, J., Harland, M., Randerson‐Moor, J. A., & Bishop, D. T. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)71010-5 · Cited by 69
Self-citationYoung, A. M., Marsden, J. R., Goodman, A. G., et al. (2001) · Clinical Oncology · doi:10.1053/clon.2001.9314 · Cited by 64
Davar, D., Tarhini, A. A., & Kirkwood, J. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31824f118b · Cited by 62
Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanoma
Moloney, F. J., & Menzies, S. W. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2010.01140.x · Cited by 45
Dermoscopic Features of Difficult Melanoma
Pizzichetta, M. A., Stanganelli, I., BONO, R., Soyer, H. P., Magi, S., Canzonieri, V., Lanzanova, G., Annessi, G., Massone, C., Cerroni, L., et al. (2007) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2007.33015.x · Cited by 44
Tjin, E. P. M., Konijnenberg, D., Krebbers, G., Mallo, H. A., Drijfhout, J. W., Franken, K. L. M. C., van der Horst, C. M. A. M., Bos, J. D., Nieweg, O. E., Kroon, B. B. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0230 · Cited by 37
de Snoo, F. A., Kroon, M. W., Bergman, W., ter Huurne, J., Houwing‐Duistermaat, J. J., van Mourik, L., Snels, D. G. C. T. M., Breuning, M. H., Willemze, R., Frants, R. R., et al. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.01.010 · Cited by 34
Cited by
Adjuvant pembrolizumab versus placebo in resected stage III melanoma
Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802357 · Cited by 1,906
Self-citationMcArthur, G. A., Chapman, P. B., Robert, C., Larkin, J., Haanen, J. B., Dummer, R., Ribas, A., Hogg, D., Hamid, O., Ascierto, P. A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70012-9 · Cited by 977
Self-citationGuidelines of care for the management of primary cutaneous melanoma
Bichakjian, C. K., Halpern, A. C., Johnson, T. M., Foote Hood, A., Grichnik, J. M., Swetter, S. M., Tsao, H., Barbosa, V. H., Chuang, T.-Y., Duvic, M., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.031 · Cited by 616
Skin cancer and new treatment perspectives: A review
Simões, M. C. F., Sousa, J. J. S., & Pais, A. A. C. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.001 · Cited by 414
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
Metadata
- Authors
- Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Bastholt, L., Grob, J.-J., Malvehy, J., Newton-Bishop, J., Stratigos, A. J., Pehamberger, H., & Eggermont, A. M.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 63
- Pages
- 201-217
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2066717393
- Cited by
- 605
- References
- 122
- FWCI
- 41.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.